|
Volumn 347, Issue 11, 2002, Pages 852-854
|
Neuroblastoma screening in early life [2] (multiple letters)
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COHORT ANALYSIS;
EARLY DIAGNOSIS;
HUMAN;
INFANT;
INFANT MORTALITY;
JAPAN;
LETTER;
MAJOR CLINICAL STUDY;
METABOLIC DISORDER;
NEUROBLASTOMA;
NEWBORN;
NEWBORN DISEASE;
NEWBORN SCREENING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
INCIDENCE;
MASS SCREENING;
NOTE;
SURVIVAL RATE;
AUSTRIA;
LABORATORY DIAGNOSIS;
MORTALITY;
LEGAL ASPECT;
STANDARD;
UNITED STATES;
GANGLIONEUROMA;
GERMANY;
HUMANS;
INCIDENCE;
INFANT;
JAPAN;
MASS SCREENING;
NEUROBLASTOMA;
SURVIVAL RATE;
AUSTRIA;
FALSE NEGATIVE REACTIONS;
INFANT, NEWBORN;
NEONATAL SCREENING;
UNITED STATES;
GANGLIONEUROMA;
GERMANY;
|
EID: 0037068649
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200209123471116 Document Type: Letter |
Times cited : (1)
|
References (0)
|